Correlation Between Jazz Pharmaceuticals and BECLE SAB

Can any of the company-specific risk be diversified away by investing in both Jazz Pharmaceuticals and BECLE SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jazz Pharmaceuticals and BECLE SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jazz Pharmaceuticals plc and BECLE SAB DE, you can compare the effects of market volatilities on Jazz Pharmaceuticals and BECLE SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jazz Pharmaceuticals with a short position of BECLE SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jazz Pharmaceuticals and BECLE SAB.

Diversification Opportunities for Jazz Pharmaceuticals and BECLE SAB

-0.83

Correlation Coefficient

Jazz Pharmaceuticals  BECLE SAB

Pay attention - limited upside

The 3 months correlation between Jazz and BECLE is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Jazz Pharmaceuticals plc and BECLE SAB DE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BECLE SAB DE and Jazz Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jazz Pharmaceuticals plc are associated (or correlated) with BECLE SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BECLE SAB DE has no effect on the direction of Jazz Pharmaceuticals i.e., Jazz Pharmaceuticals and BECLE SAB go up and down completely randomly.

Pair Corralation between Jazz Pharmaceuticals and BECLE SAB

Assuming the 90 days horizon Jazz Pharmaceuticals plc is expected to generate 0.61 times more return on investment than BECLE SAB. However, Jazz Pharmaceuticals plc is 1.64 times less risky than BECLE SAB. It trades about 0.15 of its potential returns per unit of risk. BECLE SAB DE is currently generating about -0.08 per unit of risk. If you would invest  9,984  in Jazz Pharmaceuticals plc on September 28, 2024 and sell it today you would earn a total of  1,901  from holding Jazz Pharmaceuticals plc or generate 19.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Jazz Pharmaceuticals plc  vs.  BECLE SAB DE

Jazz Pharmaceuticals plc

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Jazz Pharmaceuticals plc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Jazz Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

BECLE SAB DE

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BECLE SAB DE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Jazz Pharmaceuticals and BECLE SAB

The main advantage of trading using opposite Jazz Pharmaceuticals and BECLE SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jazz Pharmaceuticals position performs unexpectedly, BECLE SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BECLE SAB will offset losses from the drop in BECLE SAB's long position.

The idea behind Jazz Pharmaceuticals plc and BECLE SAB DE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.